Infections and systemic lupus erythematosus

To determine the incidence of infections in a population of systemic lupus erythematosus individuals and the characteristics of infections regarding original site, as well as to study the possible associations between infections and treatment. An analytical retrospective study using data from medica...

Full description

Saved in:
Bibliographic Details
Published in:Einstein (São Paulo, Brazil) Vol. 14; no. 1; pp. 47 - 51
Main Authors: Skare, Thelma Larocca, Dagostini, Jéssica Scherer, Zanardi, Patricia Imai, Nisihara, Renato Mitsunori
Format: Journal Article
Language:English
Published: Brazil Instituto Israelita de Ensino e Pesquisa Albert Einstein 01-01-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract To determine the incidence of infections in a population of systemic lupus erythematosus individuals and the characteristics of infections regarding original site, as well as to study the possible associations between infections and treatment. An analytical retrospective study using data from medical charts of systemic lupus erythematosus patients from a single university hospital. A total of 144 patients followed up for five years were included. Data collected comprised age of patients and age at onset of lupus, sex and ethnicity, disease duration before the study period, medications, cumulative dose of prednisone, occurrence of infections and their original site. The most frequent infections were urinary tract infections (correlated to use of prednisone - p<0.0001 and cyclophosphamide - p=0.045), upper airways infections (correlated to use of prednisone - p=0.0004, mycophenolate mofetil - p=0.0005, and cyclosporine - p=0.025), and pneumonia (associated to prednisone - p=0.017). Prednisone was the drug more often associated with presence of infections, pointing to the need for a more judicious management of this drug.
AbstractList ABSTRACT Objective To determine the incidence of infections in a population of systemic lupus erythematosus individuals and the characteristics of infections regarding original site, as well as to study the possible associations between infections and treatment. Methods An analytical retrospective study using data from medical charts of systemic lupus erythematosus patients from a single university hospital. A total of 144 patients followed up for five years were included. Data collected comprised age of patients and age at onset of lupus, sex and ethnicity, disease duration before the study period, medications, cumulative dose of prednisone, occurrence of infections and their original site. Results The most frequent infections were urinary tract infections (correlated to use of prednisone − p<0.0001 and cyclophosphamide − p=0.045), upper airways infections (correlated to use of prednisone − p=0.0004, mycophenolate mofetil − p=0.0005, and cyclosporine − p=0.025), and pneumonia (associated to prednisone − p=0.017). Conclusion Prednisone was the drug more often associated with presence of infections, pointing to the need for a more judicious management of this drug.
To determine the incidence of infections in a population of systemic lupus erythematosus individuals and the characteristics of infections regarding original site, as well as to study the possible associations between infections and treatment. An analytical retrospective study using data from medical charts of systemic lupus erythematosus patients from a single university hospital. A total of 144 patients followed up for five years were included. Data collected comprised age of patients and age at onset of lupus, sex and ethnicity, disease duration before the study period, medications, cumulative dose of prednisone, occurrence of infections and their original site. The most frequent infections were urinary tract infections (correlated to use of prednisone - p<0.0001 and cyclophosphamide - p=0.045), upper airways infections (correlated to use of prednisone - p=0.0004, mycophenolate mofetil - p=0.0005, and cyclosporine - p=0.025), and pneumonia (associated to prednisone - p=0.017). Prednisone was the drug more often associated with presence of infections, pointing to the need for a more judicious management of this drug.
ABSTRACT Objective To determine the incidence of infections in a population of systemic lupus erythematosus individuals and the characteristics of infections regarding original site, as well as to study the possible associations between infections and treatment. Methods An analytical retrospective study using data from medical charts of systemic lupus erythematosus patients from a single university hospital. A total of 144 patients followed up for five years were included. Data collected comprised age of patients and age at onset of lupus, sex and ethnicity, disease duration before the study period, medications, cumulative dose of prednisone, occurrence of infections and their original site. Results The most frequent infections were urinary tract infections (correlated to use of prednisone − p<0.0001 and cyclophosphamide − p=0.045), upper airways infections (correlated to use of prednisone − p=0.0004, mycophenolate mofetil − p=0.0005, and cyclosporine − p=0.025), and pneumonia (associated to prednisone − p=0.017). Conclusion Prednisone was the drug more often associated with presence of infections, pointing to the need for a more judicious management of this drug. RESUMO Objetivo Determinar a incidência de infecções em uma população com lúpus eritematoso sistêmico e a caracterização das mesmas quanto aos locais de origem, assim como estudar possíveis associações das infecções com a terapêutica utilizada. Métodos Estudo retrospectivo analítico utilizando dados de prontuários de indivíduos com lúpus eritematoso sistêmico de um único hospital universitário. Foram investigados 144 pacientes acompanhados pelo período de 5 anos. Os dados coletados incluíam idade do paciente e idade de início do lúpus, sexo e etnia, tempo de duração da doença antes do período do estudo, medicamentos administrados, dose cumulativa de prednisona, ocorrência de infecções e seu local de origem. Resultados As infecções mais observadas foram as do trato urinário (correlacionadas com o uso de prednisona − p<0,0001, e ciclofosfamida − p=0,045), infecções das vias aéreas superiores (correlacionadas com o uso de prednisona − p=0,0004, micofenolato de mofetila − p=0,0005 e ciclosporina − p=0,025) e pneumonia (correlacionadas ao uso de prednisona − p=0,017). Conclusão A prednisona foi o medicamento mais associado com a presença de infecções, apontando para a necessidade de um manejo mais judicioso desse medicamento.
Author Nisihara, Renato Mitsunori
Skare, Thelma Larocca
Dagostini, Jéssica Scherer
Zanardi, Patricia Imai
AuthorAffiliation 1 Faculdade Evangélica do Paraná, Curitiba, PR, Brazil
2 Universidade Positivo, Curitiba, PR, Brazil
AuthorAffiliation_xml – name: 2 Universidade Positivo, Curitiba, PR, Brazil
– name: 1 Faculdade Evangélica do Paraná, Curitiba, PR, Brazil
– name: Faculdade Evangélica do Paraná
– name: Universidade Positivo
Author_xml – sequence: 1
  givenname: Thelma Larocca
  surname: Skare
  fullname: Skare, Thelma Larocca
  organization: Faculdade Evangélica do Paraná, Curitiba, PR, Brazil
– sequence: 2
  givenname: Jéssica Scherer
  surname: Dagostini
  fullname: Dagostini, Jéssica Scherer
  organization: Faculdade Evangélica do Paraná, Curitiba, PR, Brazil
– sequence: 3
  givenname: Patricia Imai
  surname: Zanardi
  fullname: Zanardi, Patricia Imai
  organization: Faculdade Evangélica do Paraná, Curitiba, PR, Brazil
– sequence: 4
  givenname: Renato Mitsunori
  surname: Nisihara
  fullname: Nisihara, Renato Mitsunori
  organization: Universidade Positivo, Curitiba, PR, Brazil
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27074234$$D View this record in MEDLINE/PubMed
BookMark eNpdkU1P3DAQhi1EVRbaf4DQ3lHoeOzYzgUJIWhXQuLQ9mw5zhiyysYrO0Haf0-WwKr0YFn-eJ4ZzXvKjvvYE2PnHK54WcGP31zpqpAlGASubh6FrOCILVBwXShhymO2OPw4Yac5rwEUV6b6yk5Qg5Yo5IJdrvpAfmhjn5eub5Z5lwfatH7ZjdsxLynthmfauCHmMX9jX4LrMn1_38_Y3_u7P7e_iofHn6vbm4fCl1wMhVRBU4nGoAqq5NPBaTRCEPqayGuovEfUBhEEksAahWuCqT1yV9beiTO2mr1NdGu7Te3GpZ2NrrVvFzE9WZeG1ndkQTVICgKf9DJIUzcyaMch6JqH2vDJdTW7sm-pi3Ydx9RPzdu38dmP8QEAn5bUE3A9A9ux3lDjqR-S6z518fmlb5_tU3yx0mis-F4gZ4FPMedE4cBysPvk_is9JzdhF__WPUAfUYlX6X-UQA
CitedBy_id crossref_primary_10_47456_bjpe_v9i1_39945
crossref_primary_10_1016_j_biopha_2019_109122
crossref_primary_10_1177_09612033221135884
crossref_primary_10_3233_CH_180492
crossref_primary_10_4103_injr_injr_65_21
crossref_primary_10_1007_s00296_023_05370_x
crossref_primary_10_1016_j_rcreue_2020_07_003
crossref_primary_10_1002_ccr3_5265
crossref_primary_10_1177_0961203319882498
crossref_primary_10_1016_j_rcreu_2020_07_005
Cites_doi 10.1016/j.autrev.2015.07.003
10.1191/0961203302lu170oa
10.1080/00365540902744741
10.1097/RHU.0b013e3181d52ed7
10.1191/096120301671376017
10.1177/0961203310374486
10.1186/ar2764
10.1177/0961203314543918
10.1016/0002-9343(76)90431-9
10.1191/096120301675075008
10.1016/j.clinthera.2013.03.001
10.1177/0961203315588575
10.1191/0961203305LU2111OA
10.1016/j.rdc.2009.03.003
10.1177/0961203313493032
10.1177/0961203312470186
10.1177/0961203313490434
10.1177/0961203307086503
10.1177/0961203307077987
10.1002/art.1780400928
10.1177/0961203308093458
10.1177/0961203306071919
10.1191/0961203303lu1028oa
10.1016/j.medmal.2007.07.003
10.1177/0961203309345776
ContentType Journal Article
Copyright This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright_xml – notice: This work is licensed under a Creative Commons Attribution 4.0 International License.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
GPN
DOA
DOI 10.1590/S1679-45082016AO3490
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
SciELO
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Infecções e lúpus eritematoso sistêmico
EISSN 2317-6385
1679-4508
EndPage 51
ExternalDocumentID oai_doaj_org_article_06d2e60f133e4f48bd4f7a10f7b1fb81
S1679_45082016000100047
10_1590_S1679_45082016AO3490
27074234
Genre Journal Article
GroupedDBID 1CY
29G
2WC
53G
5GY
ABDBF
ABDHV
ABXHO
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APOWU
AZFZN
BAWUL
BCNDV
C1A
CGR
CUY
CVF
DIK
E3Z
EBD
ECM
EIF
EMOBN
ESX
GROUPED_DOAJ
HYE
IPNFZ
KQ8
M48
MK0
M~E
NPM
OK1
PGMZT
RIG
RNS
RPM
RSC
SCD
SV3
AAYXX
CITATION
5PM
GPN
ID FETCH-LOGICAL-c513t-46f7e528826f651f7ea72833e2cbeec709cc227822032e32b23adf8bc21a5bca3
IEDL.DBID RPM
ISSN 1679-4508
2317-6385
IngestDate Tue Oct 22 14:55:46 EDT 2024
Tue Nov 19 21:48:28 EST 2024
Tue Sep 17 21:20:26 EDT 2024
Fri Nov 22 00:47:51 EST 2024
Sat Nov 02 12:29:35 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Keywords Infecções urinárias/etiologia
systemic/complications
Imunossupressão
Immunosuppression
Urinary tract infection/etiology
Lupus eryithematosus
Lúpus eritematoso sistêmico/complicações
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This work is licensed under a Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c513t-46f7e528826f651f7ea72833e2cbeec709cc227822032e32b23adf8bc21a5bca3
Notes Conflict of interest: none.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872917/
PMID 27074234
PageCount 5
ParticipantIDs doaj_primary_oai_doaj_org_article_06d2e60f133e4f48bd4f7a10f7b1fb81
scielo_journals_S1679_45082016000100047
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4872917
crossref_primary_10_1590_S1679_45082016AO3490
pubmed_primary_27074234
PublicationCentury 2000
PublicationDate 2016-01-01
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – month: 01
  year: 2016
  text: 2016-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Brazil
PublicationPlace_xml – name: Brazil
PublicationTitle Einstein (São Paulo, Brazil)
PublicationTitleAlternate Einstein (Sao Paulo)
PublicationYear 2016
Publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
Publisher_xml – name: Instituto Israelita de Ensino e Pesquisa Albert Einstein
References Danza A (ref7) 2013; 22
Chatham WW (ref16) 2001; 10
Jeong SJ (ref9) 2009; 41
Khalifa M (ref5) 2007; 37
Relle M (ref11) 2015; 14
Petri M (ref21) 2004; 13
Nossent J (ref2) 2007; 16
Sisó A (ref12) 2008; 17
Koh JH (ref22) 2015; 21
Navarra SV (ref4) 2010; 19
Skare TL (ref1) 2007
Luijten RK (ref13) 2014; 23
Urowitz MB (ref3) 1976; 60
Navarro-Zarza JE (ref15) 2010; 19
Gladman DD (ref19) 2002; 11
Borba EF (ref26) 2010; 16
Bosch X (ref8) 2006; 15
Zahr ZA (ref18) 2013; 22
Chakravarty EF (ref25) 2013; 22
Ruiz-Irastorza G (ref14) 2009; 11
Pisoni CN (ref24) 2005; 14
Hochberg MC (ref10) 1997; 40
Shah M (ref17) 2013; 35
Duran-Barragan S (ref23) 2008; 17
Takada K (ref20) 2001; 10
Cuchacovich R (ref6) 2009; 35
2009; 11
2009; 35
2015; 14
2009; 41
1997; 40
2010; 16
2013; 22
2010; 19
2013; 35
1976; 60
2006; 15
2008; 17
2002; 11
2004; 13
2015; 21
Skare, TL 2007
2014; 23
2007; 37
2007; 16
2001; 10
2005; 14
References_xml – volume: 14
  start-page: 1005
  issue: 11
  year: 2015
  ident: ref11
  article-title: Genetics and novel aspects of therapies in systemic lupus erythematosus
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2015.07.003
  contributor:
    fullname: Relle M
– volume: 11
  start-page: 234
  issue: 4
  year: 2002
  ident: ref19
  article-title: The nature and outcome of infection in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/0961203302lu170oa
  contributor:
    fullname: Gladman DD
– volume: 41
  start-page: 268
  issue: 4
  year: 2009
  ident: ref9
  article-title: Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus
  publication-title: Scand J Infect Dis
  doi: 10.1080/00365540902744741
  contributor:
    fullname: Jeong SJ
– volume: 16
  start-page: 119
  issue: 3
  year: 2010
  ident: ref26
  article-title: Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus
  publication-title: J Clin Rheumatol
  doi: 10.1097/RHU.0b013e3181d52ed7
  contributor:
    fullname: Borba EF
– volume: 10
  start-page: 154
  issue: 3
  year: 2001
  ident: ref20
  article-title: Cyclophosphamide for the treatment of systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/096120301671376017
  contributor:
    fullname: Takada K
– volume: 19
  start-page: 1419
  issue: 12
  year: 2010
  ident: ref4
  article-title: Infections in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203310374486
  contributor:
    fullname: Navarra SV
– volume: 11
  issue: 4
  year: 2009
  ident: ref14
  article-title: Predictors of major infections in systemic lupus erythematosus
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar2764
  contributor:
    fullname: Ruiz-Irastorza G
– volume: 23
  start-page: 1512
  issue: 14
  year: 2014
  ident: ref13
  article-title: Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections
  publication-title: Lupus
  doi: 10.1177/0961203314543918
  contributor:
    fullname: Luijten RK
– volume: 60
  start-page: 221
  issue: 2
  year: 1976
  ident: ref3
  article-title: The bimodal mortality pattern of systemic lupus erythematosus
  publication-title: Am J Med
  doi: 10.1016/0002-9343(76)90431-9
  contributor:
    fullname: Urowitz MB
– volume: 10
  start-page: 140
  issue: 3
  year: 2001
  ident: ref16
  article-title: Treatment of lupus with corticosteroids
  publication-title: Lupus
  doi: 10.1191/096120301675075008
  contributor:
    fullname: Chatham WW
– volume: 35
  start-page: 486
  issue: 4
  year: 2013
  ident: ref17
  article-title: Cumulative burden of oral corticosteroid adverse effects and the economic implications of corticosteroid use in patients whit systemic lupus erythematosus
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2013.03.001
  contributor:
    fullname: Shah M
– year: 2007
  ident: ref1
  contributor:
    fullname: Skare TL
– volume: 21
  start-page: 1300
  issue: 12
  year: 2015
  ident: ref22
  article-title: Lupus cystitis in Korean patients with systemic lupus erythematosus: risk factors and clinical outcomes
  publication-title: Lupus
  doi: 10.1177/0961203315588575
  contributor:
    fullname: Koh JH
– volume: 14
  start-page: s9
  year: 2005
  ident: ref24
  article-title: Mycophenolate mofetil and systemic lupus erythematosus: an overview
  publication-title: Lupus
  doi: 10.1191/0961203305LU2111OA
  contributor:
    fullname: Pisoni CN
– volume: 35
  start-page: 75
  issue: 1
  year: 2009
  ident: ref6
  article-title: Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus
  publication-title: Rheum Dis Clin North Am
  doi: 10.1016/j.rdc.2009.03.003
  contributor:
    fullname: Cuchacovich R
– volume: 22
  start-page: 1286
  issue: 12
  year: 2013
  ident: ref7
  article-title: Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
  publication-title: Lupus
  doi: 10.1177/0961203313493032
  contributor:
    fullname: Danza A
– volume: 22
  start-page: 238
  issue: 3
  year: 2013
  ident: ref25
  article-title: Increased incidence of herpes zoster among patients with systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203312470186
  contributor:
    fullname: Chakravarty EF
– volume: 22
  start-page: 697
  issue: 7
  year: 2013
  ident: ref18
  article-title: Predictors of corticosteroid tapering in SLE patients: the Hopkins Lupus Cohort
  publication-title: Lupus
  doi: 10.1177/0961203313490434
  contributor:
    fullname: Zahr ZA
– volume: 17
  start-page: 281
  issue: 4
  year: 2008
  ident: ref12
  article-title: Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival
  publication-title: Lupus
  doi: 10.1177/0961203307086503
  contributor:
    fullname: Sisó A
– volume: 16
  start-page: 309
  issue: 5
  year: 2007
  ident: ref2
  article-title: Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual
  publication-title: Lupus
  doi: 10.1177/0961203307077987
  contributor:
    fullname: Nossent J
– volume: 40
  issue: 9
  year: 1997
  ident: ref10
  article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780400928
  contributor:
    fullname: Hochberg MC
– volume: 17
  start-page: 1117
  issue: 12
  year: 2008
  ident: ref23
  article-title: Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203308093458
  contributor:
    fullname: Duran-Barragan S
– volume: 15
  start-page: 584
  issue: 9
  year: 2006
  ident: ref8
  article-title: Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients
  publication-title: Lupus
  doi: 10.1177/0961203306071919
  contributor:
    fullname: Bosch X
– volume: 13
  start-page: 366
  issue: 5
  year: 2004
  ident: ref21
  article-title: Cyclophosphamide: new approaches for systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/0961203303lu1028oa
  contributor:
    fullname: Petri M
– volume: 37
  start-page: 792
  issue: 12
  year: 2007
  ident: ref5
  article-title: Infections in systemic lupus erythematosus
  publication-title: Med Mal Infect
  doi: 10.1016/j.medmal.2007.07.003
  contributor:
    fullname: Khalifa M
– volume: 19
  start-page: 43
  issue: 1
  year: 2010
  ident: ref15
  article-title: Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203309345776
  contributor:
    fullname: Navarro-Zarza JE
– year: 2007
  publication-title: Reumatologia: princípios e prática
  contributor:
    fullname: Skare, TL
– volume: 40
  issue: 9
  year: 1997
  article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum
– volume: 16
  start-page: 309
  issue: 5
  year: 2007
  end-page: 317
  article-title: Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual
  publication-title: Lupus
– volume: 14
  start-page: 1005
  issue: 11
  year: 2015
  end-page: 1018
  article-title: Genetics and novel aspects of therapies in systemic lupus erythematosus
  publication-title: Autoimmun Rev
– volume: 37
  start-page: 792
  issue: 12
  year: 2007
  end-page: 795
  article-title: Infections in systemic lupus erythematosus
  publication-title: Med Mal Infect
– volume: 17
  start-page: 281
  issue: 4
  year: 2008
  end-page: 288
  article-title: Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival
  publication-title: Lupus
– volume: 35
  start-page: 75
  issue: 1
  year: 2009
  end-page: 93
  article-title: Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus
  publication-title: Rheum Dis Clin North Am
– volume: 11
  start-page: 234
  issue: 4
  year: 2002
  end-page: 239
  article-title: The nature and outcome of infection in systemic lupus erythematosus
  publication-title: Lupus
– volume: 19
  start-page: 43
  issue: 1
  year: 2010
  end-page: 48
  article-title: Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus
  publication-title: Lupus
– volume: 10
  start-page: 154
  issue: 3
  year: 2001
  end-page: 161
  article-title: Cyclophosphamide for the treatment of systemic lupus erythematosus
  publication-title: Lupus
– volume: 22
  start-page: 697
  issue: 7
  year: 2013
  end-page: 701
  article-title: Predictors of corticosteroid tapering in SLE patients: the Hopkins Lupus Cohort
  publication-title: Lupus
– volume: 13
  start-page: 366
  issue: 5
  year: 2004
  end-page: 371
  article-title: Cyclophosphamide: new approaches for systemic lupus erythematosus
  publication-title: Lupus
– volume: 14
  start-page: s9
  year: 2005
  end-page: 11
  article-title: Mycophenolate mofetil and systemic lupus erythematosus: an overview
  publication-title: Lupus
– volume: 16
  start-page: 119
  issue: 3
  year: 2010
  end-page: 122
  article-title: Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus
  publication-title: J Clin Rheumatol
– volume: 41
  start-page: 268
  issue: 4
  year: 2009
  end-page: 274
  article-title: Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus
  publication-title: Scand J Infect Dis
– volume: 35
  start-page: 486
  issue: 4
  year: 2013
  end-page: 497
  article-title: Cumulative burden of oral corticosteroid adverse effects and the economic implications of corticosteroid use in patients whit systemic lupus erythematosus
  publication-title: Clin Ther
– volume: 17
  start-page: 1117
  issue: 12
  year: 2008
  end-page: 1121
  article-title: Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus
  publication-title: Lupus
– volume: 22
  start-page: 238
  issue: 3
  year: 2013
  end-page: 244
  article-title: Increased incidence of herpes zoster among patients with systemic lupus erythematosus
  publication-title: Lupus
– volume: 11
  issue: 4
  year: 2009
  article-title: Predictors of major infections in systemic lupus erythematosus
  publication-title: Arthritis Res Ther
– volume: 60
  start-page: 221
  issue: 2
  year: 1976
  end-page: 225
  article-title: The bimodal mortality pattern of systemic lupus erythematosus
  publication-title: Am J Med
– volume: 22
  start-page: 1286
  issue: 12
  year: 2013
  end-page: 1294
  article-title: Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
  publication-title: Lupus
– volume: 10
  start-page: 140
  issue: 3
  year: 2001
  end-page: 147
  article-title: Treatment of lupus with corticosteroids
  publication-title: Lupus
– volume: 19
  start-page: 1419
  issue: 12
  year: 2010
  end-page: 1424
  article-title: Infections in systemic lupus erythematosus
  publication-title: Lupus
– volume: 23
  start-page: 1512
  issue: 14
  year: 2014
  end-page: 1516
  article-title: Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections
  publication-title: Lupus
– volume: 21
  start-page: 1300
  issue: 12
  year: 2015
  end-page: 1307
  article-title: Lupus cystitis in Korean patients with systemic lupus erythematosus: risk factors and clinical outcomes
  publication-title: Lupus
– volume: 15
  start-page: 584
  issue: 9
  year: 2006
  end-page: 589
  article-title: Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients
  publication-title: Lupus
SSID ssj0061689
Score 2.1044257
Snippet To determine the incidence of infections in a population of systemic lupus erythematosus individuals and the characteristics of infections regarding original...
ABSTRACT Objective To determine the incidence of infections in a population of systemic lupus erythematosus individuals and the characteristics of infections...
SourceID doaj
scielo
pubmedcentral
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 47
SubjectTerms Adolescent
Adult
Aged
Anti-Inflammatory Agents - therapeutic use
Antirheumatic Agents - therapeutic use
Brazil - epidemiology
Cyclophosphamide - therapeutic use
Female
Follow-Up Studies
Hospitals, University - statistics & numerical data
Humans
Imunossupressão
Incidence
Infecções urinárias/etiologia
Lupus Erythematosus, Systemic - complications
Lupus Erythematosus, Systemic - drug therapy
Lupus Erythematosus, Systemic - epidemiology
Lúpus eritematoso sistêmico/complicações
Male
MEDICINE, GENERAL & INTERNAL
Middle Aged
Original
Photosensitivity Disorders - complications
Prednisone - therapeutic use
Respiratory Tract Infections - drug therapy
Respiratory Tract Infections - etiology
Retrospective Studies
Urinary Tract Infections - drug therapy
Urinary Tract Infections - etiology
Young Adult
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELagQogF8aa8lAGJyapjx3Y6FmjVBRgKEltkO7ZAQgGRZuDfcxeHqmVhYcxDzuU7O_ddbH9HyCULwkFcYNQPjaeoV0JtLiUFpm1dMJkOJe53ns70_XN-O0aZnEWpL1wTFuWBI3ADpkruFQuQS_ksZLkts6BNyoK2abB5THyY-kmm4jdYpaotfgfkRVPoYbLbNCeHbDDDiQewqo19avQgMvweLwWlVrt_KSD9Xiy5gbHpbTkMTXbIdscfk1G0e5es-WqPbN51M-T7BAZ8XF1V1YmpyiQqNb-65K35aOrEf35Fmdb3uqkPyNNk_HgzpV1BBOpkKuY0U0F7yYEUq6BkCgdGAz0QnjvrvdNs6BxubeVYFt0LbrkwZcit46mR1hlxSHrVe-WPSYIzrsYGB7jKrAQwrCqB_EiXy8BSn_UJ_UGk-Ii6FwXmC4Bg0SJYrCLYJ9cI2-JeVK1uT4Avi86XxV--7JOjiPWiGa4xdxdgjl7xwspzVq9Ury-tSjZkYhxy0T65iv4qusFZ_7IfWS4yW33yH69wSraw0fiT5oz05p-NPyfrddlctD30G9Y05RI
  priority: 102
  providerName: Directory of Open Access Journals
Title Infections and systemic lupus erythematosus
URI https://www.ncbi.nlm.nih.gov/pubmed/27074234
https://pubmed.ncbi.nlm.nih.gov/PMC4872917
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082016000100047&lng=en&tlng=en
https://doaj.org/article/06d2e60f133e4f48bd4f7a10f7b1fb81
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB51UVVxQfQBTWlXOVTqKazfzh4pD4EQbSVaqbfIdmy60pJdbciBf18_khXhyC1xItuasTPfxDPfAHxFjhpvF1Bh58oWga-k0CXnhUfa2jjFpKtDvvPlrfzxtzw7DzQ5fMiFiUH7Ri-Om-X9cbP4F2Mr1_dmNsSJzX7dnHqQTbybMZvAxF8MLnr6_AosYt27cLzgx0Zlny_H52h2u230Zk-c_KRsHirBERkcRMpGpiky-D8xS89DJl8HC7V8aowu9mGvR5H5SZrtW3hlm3fw5qY_J38PftunGKumzVVT54mveWHyZbfu2txuHhNZ66rt2g_w5-L89-ll0ZdFKAzH9KFgwknLiYfGwgmO_Y2SHiRQS4y21kg0NyYkuJJQHN1SoglVtSu1IVhxbRQ9gJ1m1diPkIdzV6WdcZhyVnu5aFF7CMRNyR3ClmVQDBKp1on9ogpegxdmFYVZjYWZwfcgtu27gbs6Nqw2d1WvwQqJmliB_JjUMsdKXTMnFUZOaux0iTM4TLLedjMoKAM50sJonPETv3QiV3a_VDL4lvRV9Vu0fTb_gHUDvpWfXjzGEeyGntL_mc-w87Dp7BeYtHU39Vj96noa_f1pXK3_ATUn5yQ
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4VqNpeoKWvAG1zQOoprN_OHnlqq7IUCSpxi2zHbldasqsNOfTf146TFeHIMXbkSeaLPd_EM2OAQ-So8XYBZXasbBbqlWQ65zzzTFsbp5h0Zch3ntzIq7v87DyUyeF9LkwbtG_07Kia3x9Vs79tbOXy3oz6OLHR9fTUk2zi3YzRBmz5-YpQ76THBVhg0Z58FzYYvHSUdxlzfIxGN-tGb_jE8S_KxuEsOCKDi0jZwDi1NfwfGaanQZMvg42aPzZHFzvPfJG3sN3xz_Q4dr-DF7bahVfTbof9PfgFI0ZnVXWqqjKNlZ5nJp03y6ZO7epfLPO6qJv6A_y-OL89nWTdgQqZ4Zg-ZEw4aTnxpFo4wbG_UNLTC2qJ0dYaicbGhNRYEo5Vt5RoQlXpcm0IVlwbRT_CZrWo7GdIw46t0s44TDkrvT61KD154ibnDmHLEsh6TRbLWDejCP6GB6FoQSiGICRwEtS9vjdUvW4bFqs_RaeyAomSWIG8TGqZY7kumZMKIyc1djrHCXyKGK2H6YFNQA7QG8gZ9nis2irbHTYJfI84F93krp88f2DJgRnLvWfL-AavJ7fTy-Lyx9XPfXgTRo1_eQ5g82HV2C-wUZfN1_Yr_w_BxPrE
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB4VWiEupU9InzlU6inEb2ePFFhRtVAkWqm3yM-y0pJdbcih_752nF0RjvQYx7KT-WLP53j8DcAn5KkJfgEVbqJcEfVKCl1xXgSmrY1XTHobzzufXcmL39XJaZTJ2aT66oP2jZ4dNvObw2Z23cdWLm9MuY4TKy_PjwPJJmGZUS6tL7fgcRiziKwX6mkSFlj02e_iJkN4AlQNp-b4BJVXm8Lg_MTRD8omMR8ckXGZSNnIQfU6_nec0_3AySfRT83vuqTp3n-8zDN4OvDQ_ChVeQ6PXPMCds6HnfaXECaOFKXVtLlqbJ4Un2cmn3fLrs3d6m-Se120XfsKfk1Pfx6fFUNihcJwTG8LJrx0nARyLbzgOFwoGWgGdcRo54xEE2PiEVkS06s7SjShyvpKG4IV10bR17DdLBp3AHncuVXaG48pZzbYVAsbSBQ3FfcIO5ZBsbZmvUz6GXVcdwQg6h6IegxEBl-iyTd1o_p1X7BY_akHs9VIWOIECn1SxzyrtGVeKoy81NjrCmewn3DaNLMGNwM5QnDUz_hOwKtX2x7wyeBzwroeBnl77_kjW44MWb55cB8fYefyZFp__3rx7S3sxkbTz553sH276tx72Gpt96H_0P8B3I_9RA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Infections+and+systemic+lupus+erythematosus&rft.jtitle=Einstein+%28Sa%CC%83o+Paulo%2C+Brazil%29&rft.au=Skare%2C+Thelma+Larocca&rft.au=Dagostini%2C+J%C3%A9ssica+Scherer&rft.au=Zanardi%2C+Patricia+Imai&rft.au=Nisihara%2C+Renato+Mitsunori&rft.date=2016-01-01&rft.pub=Instituto+Israelita+de+Ensino+e+Pesquisa+Albert+Einstein&rft.issn=1679-4508&rft.eissn=2317-6385&rft.volume=14&rft.issue=1&rft.spage=47&rft.epage=51&rft_id=info:doi/10.1590%2FS1679-45082016AO3490&rft_id=info%3Apmid%2F27074234&rft.externalDBID=PMC4872917
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1679-4508&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1679-4508&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1679-4508&client=summon